nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP3A7—Rifampicin—leprosy	0.0908	0.134	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0908	0.134	CbGbCtD
Ziprasidone—CYP3A7—Dapsone—leprosy	0.075	0.111	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Dapsone—leprosy	0.075	0.111	CbGbCtD
Ziprasidone—CYP3A5—Thalidomide—leprosy	0.0703	0.104	CbGbCtD
Ziprasidone—CYP3A5—Rifampicin—leprosy	0.0681	0.101	CbGbCtD
Ziprasidone—CYP3A5—Dapsone—leprosy	0.0562	0.083	CbGbCtD
Ziprasidone—CYP1A2—Thalidomide—leprosy	0.0524	0.0772	CbGbCtD
Ziprasidone—CYP1A2—Rifampicin—leprosy	0.0507	0.0748	CbGbCtD
Ziprasidone—CYP3A4—Rifampicin—leprosy	0.0266	0.0392	CbGbCtD
Ziprasidone—CYP3A4—Dapsone—leprosy	0.0219	0.0324	CbGbCtD
Ziprasidone—DRD5—eyelid—leprosy	0.0147	0.124	CbGeAlD
Ziprasidone—Mental state abnormal—Thalidomide—leprosy	0.00805	0.0396	CcSEcCtD
Ziprasidone—HTR1B—trigeminal nerve—leprosy	0.00665	0.056	CbGeAlD
Ziprasidone—HTR1D—trigeminal nerve—leprosy	0.00644	0.0542	CbGeAlD
Ziprasidone—HTR3A—cranial nerve—leprosy	0.00565	0.0476	CbGeAlD
Ziprasidone—Teratogenicity—Thalidomide—leprosy	0.0052	0.0256	CcSEcCtD
Ziprasidone—HRH1—nose—leprosy	0.00488	0.0411	CbGeAlD
Ziprasidone—HTR1B—cranial nerve—leprosy	0.00474	0.0399	CbGeAlD
Ziprasidone—HTR1D—cranial nerve—leprosy	0.00459	0.0386	CbGeAlD
Ziprasidone—Swelling face—Dapsone—leprosy	0.00447	0.022	CcSEcCtD
Ziprasidone—Lymphoedema—Thalidomide—leprosy	0.00446	0.0219	CcSEcCtD
Ziprasidone—CHRM5—skin epidermis—leprosy	0.00413	0.0348	CbGeAlD
Ziprasidone—Enuresis—Thalidomide—leprosy	0.00381	0.0187	CcSEcCtD
Ziprasidone—Suicide attempt—Dapsone—leprosy	0.00375	0.0184	CcSEcCtD
Ziprasidone—Hypoproteinaemia—Thalidomide—leprosy	0.00371	0.0182	CcSEcCtD
Ziprasidone—HTR7—cranial nerve—leprosy	0.00365	0.0308	CbGeAlD
Ziprasidone—Circumoral paresthesia—Thalidomide—leprosy	0.00334	0.0164	CcSEcCtD
Ziprasidone—HTR2A—trigeminal nerve—leprosy	0.0032	0.0269	CbGeAlD
Ziprasidone—DRD1—nerve—leprosy	0.003	0.0252	CbGeAlD
Ziprasidone—HTR3A—nerve—leprosy	0.00289	0.0244	CbGeAlD
Ziprasidone—Albuminuria—Dapsone—leprosy	0.00285	0.014	CcSEcCtD
Ziprasidone—Hypochromic anaemia—Thalidomide—leprosy	0.00281	0.0138	CcSEcCtD
Ziprasidone—Fungal skin infection—Thalidomide—leprosy	0.00261	0.0128	CcSEcCtD
Ziprasidone—HTR7—peripheral nervous system—leprosy	0.0024	0.0202	CbGeAlD
Ziprasidone—Parkinsonism—Thalidomide—leprosy	0.0024	0.0118	CcSEcCtD
Ziprasidone—Paraesthesia oral—Thalidomide—leprosy	0.00232	0.0114	CcSEcCtD
Ziprasidone—Grand mal convulsion—Thalidomide—leprosy	0.00229	0.0112	CcSEcCtD
Ziprasidone—HTR2A—cranial nerve—leprosy	0.00228	0.0192	CbGeAlD
Ziprasidone—Embolism venous—Thalidomide—leprosy	0.00216	0.0106	CcSEcCtD
Ziprasidone—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00213	0.0105	CcSEcCtD
Ziprasidone—Hostility—Thalidomide—leprosy	0.00197	0.00967	CcSEcCtD
Ziprasidone—Vesiculobullous rash—Thalidomide—leprosy	0.00194	0.00955	CcSEcCtD
Ziprasidone—HTR2A—hindlimb—leprosy	0.00192	0.0162	CbGeAlD
Ziprasidone—Suicide attempt—Thalidomide—leprosy	0.00192	0.00944	CcSEcCtD
Ziprasidone—HTR1B—blood vessel—leprosy	0.00191	0.0161	CbGeAlD
Ziprasidone—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00187	0.00921	CcSEcCtD
Ziprasidone—HTR7—nerve—leprosy	0.00187	0.0158	CbGeAlD
Ziprasidone—HTR1D—blood vessel—leprosy	0.00185	0.0156	CbGeAlD
Ziprasidone—DRD2—nerve—leprosy	0.00177	0.0149	CbGeAlD
Ziprasidone—ADRA2A—peripheral nervous system—leprosy	0.00176	0.0148	CbGeAlD
Ziprasidone—Psoriasis—Thalidomide—leprosy	0.00173	0.00852	CcSEcCtD
Ziprasidone—Hypomagnesaemia—Thalidomide—leprosy	0.00172	0.00843	CcSEcCtD
Ziprasidone—Hypothyroidism—Thalidomide—leprosy	0.0017	0.00834	CcSEcCtD
Ziprasidone—Galactorrhoea—Thalidomide—leprosy	0.00168	0.00826	CcSEcCtD
Ziprasidone—Tooth disorder—Thalidomide—leprosy	0.00168	0.00826	CcSEcCtD
Ziprasidone—HTR2A—appendage—leprosy	0.00165	0.0139	CbGeAlD
Ziprasidone—Liver disorder—Thalidomide—leprosy	0.0016	0.00786	CcSEcCtD
Ziprasidone—Hepatomegaly—Thalidomide—leprosy	0.00154	0.00756	CcSEcCtD
Ziprasidone—Metrorrhagia—Thalidomide—leprosy	0.00153	0.0075	CcSEcCtD
Ziprasidone—Nystagmus—Thalidomide—leprosy	0.00153	0.0075	CcSEcCtD
Ziprasidone—Hyperlipidaemia—Thalidomide—leprosy	0.00151	0.00743	CcSEcCtD
Ziprasidone—Psychotic disorder—Dapsone—leprosy	0.00151	0.00742	CcSEcCtD
Ziprasidone—HTR2A—peripheral nervous system—leprosy	0.0015	0.0126	CbGeAlD
Ziprasidone—HTR7—blood vessel—leprosy	0.00147	0.0124	CbGeAlD
Ziprasidone—CHRM5—eye—leprosy	0.00147	0.0124	CbGeAlD
Ziprasidone—Albuminuria—Thalidomide—leprosy	0.00146	0.00717	CcSEcCtD
Ziprasidone—Amblyopia—Thalidomide—leprosy	0.00141	0.00693	CcSEcCtD
Ziprasidone—Nasopharyngitis—Dapsone—leprosy	0.00138	0.00679	CcSEcCtD
Ziprasidone—Rash pustular—Thalidomide—leprosy	0.00137	0.00671	CcSEcCtD
Ziprasidone—DRD4—testis—leprosy	0.00136	0.0115	CbGeAlD
Ziprasidone—Influenza—Dapsone—leprosy	0.00134	0.00656	CcSEcCtD
Ziprasidone—Acne—Thalidomide—leprosy	0.00129	0.00636	CcSEcCtD
Ziprasidone—CHRM5—skin of body—leprosy	0.00128	0.0108	CbGeAlD
Ziprasidone—Vasodilation procedure—Thalidomide—leprosy	0.00124	0.00609	CcSEcCtD
Ziprasidone—Vasodilation—Thalidomide—leprosy	0.00124	0.00609	CcSEcCtD
Ziprasidone—Jaundice cholestatic—Thalidomide—leprosy	0.00124	0.00609	CcSEcCtD
Ziprasidone—Amenorrhoea—Thalidomide—leprosy	0.00124	0.00609	CcSEcCtD
Ziprasidone—Accidental injury—Thalidomide—leprosy	0.00123	0.00605	CcSEcCtD
Ziprasidone—Photosensitivity reaction—Dapsone—leprosy	0.00122	0.00599	CcSEcCtD
Ziprasidone—Musculoskeletal stiffness—Thalidomide—leprosy	0.00121	0.00597	CcSEcCtD
Ziprasidone—Arthropathy—Thalidomide—leprosy	0.0012	0.00589	CcSEcCtD
Ziprasidone—Hypocalcaemia—Thalidomide—leprosy	0.00119	0.00585	CcSEcCtD
Ziprasidone—Oliguria—Thalidomide—leprosy	0.00118	0.00581	CcSEcCtD
Ziprasidone—Hyperuricaemia—Thalidomide—leprosy	0.00117	0.00577	CcSEcCtD
Ziprasidone—Drug interaction—Thalidomide—leprosy	0.00117	0.00577	CcSEcCtD
Ziprasidone—HTR2A—nerve—leprosy	0.00117	0.00984	CbGeAlD
Ziprasidone—Neuropathy peripheral—Dapsone—leprosy	0.00117	0.00574	CcSEcCtD
Ziprasidone—Dyskinesia—Thalidomide—leprosy	0.00116	0.0057	CcSEcCtD
Ziprasidone—Leukocytosis—Thalidomide—leprosy	0.00116	0.0057	CcSEcCtD
Ziprasidone—HTR1E—nervous system—leprosy	0.00115	0.00973	CbGeAlD
Ziprasidone—Hypercholesterolaemia—Thalidomide—leprosy	0.00115	0.00566	CcSEcCtD
Ziprasidone—Creatinine increased—Thalidomide—leprosy	0.00114	0.00562	CcSEcCtD
Ziprasidone—Atrioventricular block—Thalidomide—leprosy	0.00112	0.00552	CcSEcCtD
Ziprasidone—Gait disturbance—Thalidomide—leprosy	0.00112	0.00549	CcSEcCtD
Ziprasidone—Coordination abnormal—Thalidomide—leprosy	0.00111	0.00545	CcSEcCtD
Ziprasidone—Blood uric acid increased—Thalidomide—leprosy	0.00111	0.00545	CcSEcCtD
Ziprasidone—H1F0—skin of body—leprosy	0.0011	0.0093	CbGeAlD
Ziprasidone—Phosphatase alkaline increased—Thalidomide—leprosy	0.00109	0.00535	CcSEcCtD
Ziprasidone—Pulmonary embolism—Thalidomide—leprosy	0.00109	0.00535	CcSEcCtD
Ziprasidone—Hyperkalaemia—Thalidomide—leprosy	0.00107	0.00526	CcSEcCtD
Ziprasidone—Pharyngitis—Dapsone—leprosy	0.00106	0.00521	CcSEcCtD
Ziprasidone—CHRM4—testis—leprosy	0.00103	0.00869	CbGeAlD
Ziprasidone—Blood urea increased—Thalidomide—leprosy	0.00103	0.00506	CcSEcCtD
Ziprasidone—Neuropathy—Thalidomide—leprosy	0.00102	0.00503	CcSEcCtD
Ziprasidone—CHRM4—nervous system—leprosy	0.00101	0.00853	CbGeAlD
Ziprasidone—Dry eye—Thalidomide—leprosy	0.00101	0.00495	CcSEcCtD
Ziprasidone—Tinnitus—Dapsone—leprosy	0.000997	0.0049	CcSEcCtD
Ziprasidone—Rash maculo-papular—Thalidomide—leprosy	0.00099	0.00487	CcSEcCtD
Ziprasidone—HTR1D—eye—leprosy	0.000983	0.00828	CbGeAlD
Ziprasidone—Lightheadedness—Thalidomide—leprosy	0.000975	0.00479	CcSEcCtD
Ziprasidone—Gynaecomastia—Thalidomide—leprosy	0.000975	0.00479	CcSEcCtD
Ziprasidone—Hypertonia—Thalidomide—leprosy	0.000955	0.00469	CcSEcCtD
Ziprasidone—Hyperkinesia—Thalidomide—leprosy	0.00095	0.00467	CcSEcCtD
Ziprasidone—Sepsis—Thalidomide—leprosy	0.000946	0.00465	CcSEcCtD
Ziprasidone—DRD3—nervous system—leprosy	0.000941	0.00793	CbGeAlD
Ziprasidone—Erythema—Dapsone—leprosy	0.000931	0.00457	CcSEcCtD
Ziprasidone—Lymphadenopathy—Thalidomide—leprosy	0.000927	0.00456	CcSEcCtD
Ziprasidone—HTR2A—blood vessel—leprosy	0.000917	0.00773	CbGeAlD
Ziprasidone—Thrombophlebitis—Thalidomide—leprosy	0.000914	0.00449	CcSEcCtD
Ziprasidone—Diabetes mellitus—Thalidomide—leprosy	0.000909	0.00447	CcSEcCtD
Ziprasidone—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000909	0.00447	CcSEcCtD
Ziprasidone—HTR6—nervous system—leprosy	0.000906	0.00763	CbGeAlD
Ziprasidone—DRD5—nervous system—leprosy	0.000882	0.00743	CbGeAlD
Ziprasidone—Eczema—Thalidomide—leprosy	0.00088	0.00432	CcSEcCtD
Ziprasidone—Vision blurred—Dapsone—leprosy	0.000877	0.00431	CcSEcCtD
Ziprasidone—Injury—Thalidomide—leprosy	0.000861	0.00423	CcSEcCtD
Ziprasidone—Renal failure acute—Thalidomide—leprosy	0.000857	0.00421	CcSEcCtD
Ziprasidone—Amnesia—Thalidomide—leprosy	0.000842	0.00414	CcSEcCtD
Ziprasidone—Increased appetite—Thalidomide—leprosy	0.000842	0.00414	CcSEcCtD
Ziprasidone—H1F0—tendon—leprosy	0.00084	0.00708	CbGeAlD
Ziprasidone—Dermatitis exfoliative—Thalidomide—leprosy	0.000838	0.00412	CcSEcCtD
Ziprasidone—Vertigo—Dapsone—leprosy	0.000836	0.00411	CcSEcCtD
Ziprasidone—Atrial fibrillation—Thalidomide—leprosy	0.000835	0.0041	CcSEcCtD
Ziprasidone—Visual disturbance—Thalidomide—leprosy	0.000835	0.0041	CcSEcCtD
Ziprasidone—Dermatitis bullous—Thalidomide—leprosy	0.000828	0.00407	CcSEcCtD
Ziprasidone—Cough—Dapsone—leprosy	0.000812	0.00399	CcSEcCtD
Ziprasidone—Hypoglycaemia—Thalidomide—leprosy	0.000811	0.00398	CcSEcCtD
Ziprasidone—Lethargy—Thalidomide—leprosy	0.000807	0.00397	CcSEcCtD
Ziprasidone—Cerebrovascular accident—Thalidomide—leprosy	0.000807	0.00397	CcSEcCtD
Ziprasidone—Hyponatraemia—Thalidomide—leprosy	0.000794	0.0039	CcSEcCtD
Ziprasidone—CHRM5—nervous system—leprosy	0.000791	0.00667	CbGeAlD
Ziprasidone—Osteoarthritis—Thalidomide—leprosy	0.000791	0.00389	CcSEcCtD
Ziprasidone—Pain in extremity—Thalidomide—leprosy	0.000791	0.00389	CcSEcCtD
Ziprasidone—Diplopia—Thalidomide—leprosy	0.000791	0.00389	CcSEcCtD
Ziprasidone—Psychotic disorder—Thalidomide—leprosy	0.000773	0.0038	CcSEcCtD
Ziprasidone—Face oedema—Thalidomide—leprosy	0.000764	0.00375	CcSEcCtD
Ziprasidone—Ataxia—Thalidomide—leprosy	0.000744	0.00365	CcSEcCtD
Ziprasidone—Tachycardia—Dapsone—leprosy	0.000741	0.00364	CcSEcCtD
Ziprasidone—Blood creatinine increased—Thalidomide—leprosy	0.000741	0.00364	CcSEcCtD
Ziprasidone—DRD2—eye—leprosy	0.00074	0.00623	CbGeAlD
Ziprasidone—Dehydration—Thalidomide—leprosy	0.000736	0.00361	CcSEcCtD
Ziprasidone—Liver function test abnormal—Thalidomide—leprosy	0.00073	0.00359	CcSEcCtD
Ziprasidone—ADRA1B—nervous system—leprosy	0.000723	0.00609	CbGeAlD
Ziprasidone—Orthostatic hypotension—Thalidomide—leprosy	0.000722	0.00355	CcSEcCtD
Ziprasidone—Hypokalaemia—Thalidomide—leprosy	0.00072	0.00354	CcSEcCtD
Ziprasidone—Breast disorder—Thalidomide—leprosy	0.000715	0.00351	CcSEcCtD
Ziprasidone—Cramp muscle—Thalidomide—leprosy	0.000712	0.0035	CcSEcCtD
Ziprasidone—H1F0—testis—leprosy	0.000696	0.00586	CbGeAlD
Ziprasidone—Insomnia—Dapsone—leprosy	0.000687	0.00338	CcSEcCtD
Ziprasidone—Influenza—Thalidomide—leprosy	0.000684	0.00336	CcSEcCtD
Ziprasidone—Dysphagia—Thalidomide—leprosy	0.000684	0.00336	CcSEcCtD
Ziprasidone—H1F0—nervous system—leprosy	0.000683	0.00575	CbGeAlD
Ziprasidone—Eosinophilia—Thalidomide—leprosy	0.000677	0.00333	CcSEcCtD
Ziprasidone—DRD1—nervous system—leprosy	0.000674	0.00568	CbGeAlD
Ziprasidone—Angina pectoris—Thalidomide—leprosy	0.000666	0.00327	CcSEcCtD
Ziprasidone—HTR3A—nervous system—leprosy	0.000651	0.00548	CbGeAlD
Ziprasidone—Upper respiratory tract infection—Thalidomide—leprosy	0.000635	0.00312	CcSEcCtD
Ziprasidone—Erectile dysfunction—Thalidomide—leprosy	0.00063	0.00309	CcSEcCtD
Ziprasidone—Photosensitivity reaction—Thalidomide—leprosy	0.000624	0.00307	CcSEcCtD
Ziprasidone—Weight increased—Thalidomide—leprosy	0.000622	0.00306	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dapsone—leprosy	0.000621	0.00305	CcSEcCtD
Ziprasidone—Weight decreased—Thalidomide—leprosy	0.000619	0.00304	CcSEcCtD
Ziprasidone—Hyperglycaemia—Thalidomide—leprosy	0.000617	0.00303	CcSEcCtD
Ziprasidone—Pneumonia—Thalidomide—leprosy	0.000613	0.00301	CcSEcCtD
Ziprasidone—Infestation NOS—Thalidomide—leprosy	0.00061	0.003	CcSEcCtD
Ziprasidone—Infestation—Thalidomide—leprosy	0.00061	0.003	CcSEcCtD
Ziprasidone—Body temperature increased—Dapsone—leprosy	0.0006	0.00295	CcSEcCtD
Ziprasidone—Abdominal pain—Dapsone—leprosy	0.0006	0.00295	CcSEcCtD
Ziprasidone—Renal failure—Thalidomide—leprosy	0.000599	0.00294	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Thalidomide—leprosy	0.000598	0.00294	CcSEcCtD
Ziprasidone—Conjunctivitis—Thalidomide—leprosy	0.000593	0.00291	CcSEcCtD
Ziprasidone—HRH1—eye—leprosy	0.000584	0.00492	CbGeAlD
Ziprasidone—Sweating—Thalidomide—leprosy	0.000584	0.00287	CcSEcCtD
Ziprasidone—Haematuria—Thalidomide—leprosy	0.000581	0.00286	CcSEcCtD
Ziprasidone—Epistaxis—Thalidomide—leprosy	0.000575	0.00283	CcSEcCtD
Ziprasidone—Bradycardia—Thalidomide—leprosy	0.000557	0.00274	CcSEcCtD
Ziprasidone—Rhinitis—Thalidomide—leprosy	0.000549	0.0027	CcSEcCtD
Ziprasidone—Hepatitis—Thalidomide—leprosy	0.000547	0.00269	CcSEcCtD
Ziprasidone—HTR1B—nervous system—leprosy	0.000546	0.0046	CbGeAlD
Ziprasidone—Hypoaesthesia—Thalidomide—leprosy	0.000544	0.00268	CcSEcCtD
Ziprasidone—CHRM2—nervous system—leprosy	0.000543	0.00458	CbGeAlD
Ziprasidone—Pharyngitis—Thalidomide—leprosy	0.000543	0.00267	CcSEcCtD
Ziprasidone—Urinary tract disorder—Thalidomide—leprosy	0.00054	0.00266	CcSEcCtD
Ziprasidone—Oedema peripheral—Thalidomide—leprosy	0.000539	0.00265	CcSEcCtD
Ziprasidone—Urethral disorder—Thalidomide—leprosy	0.000536	0.00264	CcSEcCtD
Ziprasidone—HTR1D—nervous system—leprosy	0.000529	0.00445	CbGeAlD
Ziprasidone—Visual impairment—Thalidomide—leprosy	0.000527	0.00259	CcSEcCtD
Ziprasidone—HTR2C—nervous system—leprosy	0.000524	0.00441	CbGeAlD
Ziprasidone—HTR7—tendon—leprosy	0.000518	0.00437	CbGeAlD
Ziprasidone—Eye disorder—Thalidomide—leprosy	0.000511	0.00251	CcSEcCtD
Ziprasidone—Tinnitus—Thalidomide—leprosy	0.00051	0.00251	CcSEcCtD
Ziprasidone—Cardiac disorder—Thalidomide—leprosy	0.000508	0.0025	CcSEcCtD
Ziprasidone—Angiopathy—Thalidomide—leprosy	0.000496	0.00244	CcSEcCtD
Ziprasidone—SLC6A4—nervous system—leprosy	0.000496	0.00418	CbGeAlD
Ziprasidone—CHRM1—nervous system—leprosy	0.000495	0.00417	CbGeAlD
Ziprasidone—Immune system disorder—Thalidomide—leprosy	0.000494	0.00243	CcSEcCtD
Ziprasidone—Mediastinal disorder—Thalidomide—leprosy	0.000493	0.00242	CcSEcCtD
Ziprasidone—Chills—Thalidomide—leprosy	0.000491	0.00241	CcSEcCtD
Ziprasidone—Arrhythmia—Thalidomide—leprosy	0.000489	0.0024	CcSEcCtD
Ziprasidone—HTR2A—eye—leprosy	0.000488	0.00411	CbGeAlD
Ziprasidone—Alopecia—Thalidomide—leprosy	0.000484	0.00238	CcSEcCtD
Ziprasidone—Vomiting—Dapsone—leprosy	0.000483	0.00237	CcSEcCtD
Ziprasidone—Mental disorder—Thalidomide—leprosy	0.000479	0.00236	CcSEcCtD
Ziprasidone—ADRA2C—tendon—leprosy	0.000476	0.00401	CbGeAlD
Ziprasidone—Malnutrition—Thalidomide—leprosy	0.000476	0.00234	CcSEcCtD
Ziprasidone—Headache—Dapsone—leprosy	0.000476	0.00234	CcSEcCtD
Ziprasidone—Flatulence—Thalidomide—leprosy	0.000469	0.00231	CcSEcCtD
Ziprasidone—Back pain—Thalidomide—leprosy	0.000461	0.00226	CcSEcCtD
Ziprasidone—Muscle spasms—Thalidomide—leprosy	0.000458	0.00225	CcSEcCtD
Ziprasidone—Nausea—Dapsone—leprosy	0.000451	0.00222	CcSEcCtD
Ziprasidone—CHRM3—testis—leprosy	0.000451	0.0038	CbGeAlD
Ziprasidone—Vision blurred—Thalidomide—leprosy	0.000449	0.00221	CcSEcCtD
Ziprasidone—Tremor—Thalidomide—leprosy	0.000446	0.00219	CcSEcCtD
Ziprasidone—CHRM3—nervous system—leprosy	0.000443	0.00373	CbGeAlD
Ziprasidone—HTR1A—nervous system—leprosy	0.000441	0.00371	CbGeAlD
Ziprasidone—Anaemia—Thalidomide—leprosy	0.00044	0.00216	CcSEcCtD
Ziprasidone—Agitation—Thalidomide—leprosy	0.000438	0.00215	CcSEcCtD
Ziprasidone—Angioedema—Thalidomide—leprosy	0.000435	0.00214	CcSEcCtD
Ziprasidone—HTR7—testis—leprosy	0.000429	0.00362	CbGeAlD
Ziprasidone—Vertigo—Thalidomide—leprosy	0.000428	0.0021	CcSEcCtD
Ziprasidone—Syncope—Thalidomide—leprosy	0.000427	0.0021	CcSEcCtD
Ziprasidone—Leukopenia—Thalidomide—leprosy	0.000426	0.0021	CcSEcCtD
Ziprasidone—HTR7—nervous system—leprosy	0.000421	0.00355	CbGeAlD
Ziprasidone—Palpitations—Thalidomide—leprosy	0.000421	0.00207	CcSEcCtD
Ziprasidone—Loss of consciousness—Thalidomide—leprosy	0.000419	0.00206	CcSEcCtD
Ziprasidone—Cough—Thalidomide—leprosy	0.000416	0.00204	CcSEcCtD
Ziprasidone—Hypertension—Thalidomide—leprosy	0.000411	0.00202	CcSEcCtD
Ziprasidone—ADRA1A—nervous system—leprosy	0.000406	0.00342	CbGeAlD
Ziprasidone—DRD2—testis—leprosy	0.000406	0.00342	CbGeAlD
Ziprasidone—Myalgia—Thalidomide—leprosy	0.000406	0.00199	CcSEcCtD
Ziprasidone—Chest pain—Thalidomide—leprosy	0.000406	0.00199	CcSEcCtD
Ziprasidone—Arthralgia—Thalidomide—leprosy	0.000406	0.00199	CcSEcCtD
Ziprasidone—Anxiety—Thalidomide—leprosy	0.000404	0.00199	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000403	0.00198	CcSEcCtD
Ziprasidone—KCNH2—testis—leprosy	0.0004	0.00337	CbGeAlD
Ziprasidone—DRD2—nervous system—leprosy	0.000398	0.00335	CbGeAlD
Ziprasidone—Dry mouth—Thalidomide—leprosy	0.000397	0.00195	CcSEcCtD
Ziprasidone—ADRA2C—testis—leprosy	0.000394	0.00332	CbGeAlD
Ziprasidone—KCNH2—nervous system—leprosy	0.000392	0.00331	CbGeAlD
Ziprasidone—Confusional state—Thalidomide—leprosy	0.000392	0.00193	CcSEcCtD
Ziprasidone—ADRA2C—nervous system—leprosy	0.000387	0.00326	CbGeAlD
Ziprasidone—HRH1—tendon—leprosy	0.000387	0.00326	CbGeAlD
Ziprasidone—Infection—Thalidomide—leprosy	0.000386	0.0019	CcSEcCtD
Ziprasidone—Shock—Thalidomide—leprosy	0.000382	0.00188	CcSEcCtD
Ziprasidone—Nervous system disorder—Thalidomide—leprosy	0.000381	0.00187	CcSEcCtD
Ziprasidone—Thrombocytopenia—Thalidomide—leprosy	0.000381	0.00187	CcSEcCtD
Ziprasidone—ADRA2A—tendon—leprosy	0.00038	0.0032	CbGeAlD
Ziprasidone—Tachycardia—Thalidomide—leprosy	0.000379	0.00186	CcSEcCtD
Ziprasidone—Skin disorder—Thalidomide—leprosy	0.000378	0.00186	CcSEcCtD
Ziprasidone—Hyperhidrosis—Thalidomide—leprosy	0.000376	0.00185	CcSEcCtD
Ziprasidone—Anorexia—Thalidomide—leprosy	0.000371	0.00182	CcSEcCtD
Ziprasidone—Hypotension—Thalidomide—leprosy	0.000363	0.00179	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000354	0.00174	CcSEcCtD
Ziprasidone—Insomnia—Thalidomide—leprosy	0.000352	0.00173	CcSEcCtD
Ziprasidone—Paraesthesia—Thalidomide—leprosy	0.000349	0.00172	CcSEcCtD
Ziprasidone—Dyspnoea—Thalidomide—leprosy	0.000347	0.0017	CcSEcCtD
Ziprasidone—Somnolence—Thalidomide—leprosy	0.000346	0.0017	CcSEcCtD
Ziprasidone—Dyspepsia—Thalidomide—leprosy	0.000342	0.00168	CcSEcCtD
Ziprasidone—Decreased appetite—Thalidomide—leprosy	0.000338	0.00166	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Thalidomide—leprosy	0.000336	0.00165	CcSEcCtD
Ziprasidone—Fatigue—Thalidomide—leprosy	0.000335	0.00165	CcSEcCtD
Ziprasidone—Constipation—Thalidomide—leprosy	0.000332	0.00163	CcSEcCtD
Ziprasidone—HTR2A—tendon—leprosy	0.000323	0.00272	CbGeAlD
Ziprasidone—HRH1—testis—leprosy	0.00032	0.0027	CbGeAlD
Ziprasidone—Feeling abnormal—Thalidomide—leprosy	0.00032	0.00157	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Thalidomide—leprosy	0.000318	0.00156	CcSEcCtD
Ziprasidone—ADRA2A—testis—leprosy	0.000315	0.00265	CbGeAlD
Ziprasidone—HRH1—nervous system—leprosy	0.000315	0.00265	CbGeAlD
Ziprasidone—ADRA2A—nervous system—leprosy	0.000309	0.0026	CbGeAlD
Ziprasidone—Urticaria—Thalidomide—leprosy	0.000309	0.00152	CcSEcCtD
Ziprasidone—Abdominal pain—Thalidomide—leprosy	0.000307	0.00151	CcSEcCtD
Ziprasidone—Body temperature increased—Thalidomide—leprosy	0.000307	0.00151	CcSEcCtD
Ziprasidone—Hypersensitivity—Thalidomide—leprosy	0.000286	0.00141	CcSEcCtD
Ziprasidone—Asthenia—Thalidomide—leprosy	0.000279	0.00137	CcSEcCtD
Ziprasidone—HTR2A—testis—leprosy	0.000268	0.00225	CbGeAlD
Ziprasidone—Diarrhoea—Thalidomide—leprosy	0.000266	0.00131	CcSEcCtD
Ziprasidone—HTR2A—nervous system—leprosy	0.000263	0.00221	CbGeAlD
Ziprasidone—Dizziness—Thalidomide—leprosy	0.000257	0.00126	CcSEcCtD
Ziprasidone—Vomiting—Thalidomide—leprosy	0.000247	0.00121	CcSEcCtD
Ziprasidone—Rash—Thalidomide—leprosy	0.000245	0.0012	CcSEcCtD
Ziprasidone—Dermatitis—Thalidomide—leprosy	0.000245	0.0012	CcSEcCtD
Ziprasidone—CYP2D6—testis—leprosy	0.000244	0.00205	CbGeAlD
Ziprasidone—Headache—Thalidomide—leprosy	0.000244	0.0012	CcSEcCtD
Ziprasidone—CYP3A4—nervous system—leprosy	0.000243	0.00205	CbGeAlD
Ziprasidone—CYP2D6—nervous system—leprosy	0.000239	0.00202	CbGeAlD
Ziprasidone—Nausea—Thalidomide—leprosy	0.000231	0.00113	CcSEcCtD
